Literature DB >> 17955239

Evolving concept of imaging bone marrow metastasis in the twenty-first century: critical role of FDG-PET.

Sandip Basu, Drew Torigian, Abass Alavi.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 17955239     DOI： 10.1007/s00259-007-0593-0

Source DB:  PubMed          Journal:  Eur J Nucl Med Mol Imaging        ISSN： 1619-7070            Impact factor:   10.057


× No keyword cloud information.
  52 in total

1.  A comparison of whole-body turboSTIR MR imaging and planar 99mTc-methylene diphosphonate scintigraphy in the examination of patients with suspected skeletal metastases.

Authors:  S Eustace; R Tello; V DeCarvalho; J Carey; J T Wroblicka; E R Melhem; E K Yucel
Journal:  AJR Am J Roentgenol       Date:  1997-12       Impact factor: 3.959

2.  18-F-fluorodeoxyglucose-positron emission tomography as a new approach to detect lymphomatous bone marrow.

Authors:  F Moog; M Bangerter; J Kotzerke; A Guhlmann; N Frickhofen; S N Reske
Journal:  J Clin Oncol       Date:  1998-02       Impact factor: 44.544

3.  Detection of malignant bone tumors: MR imaging vs scintigraphy.

Authors:  J A Frank; A Ling; N J Patronas; J A Carrasquillo; K Horvath; A M Hickey; A J Dwyer
Journal:  AJR Am J Roentgenol       Date:  1990-11       Impact factor: 3.959

4.  Sensitivity in detecting osseous lesions depends on anatomic localization: planar bone scintigraphy versus 18F PET.

Authors:  H Schirrmeister; A Guhlmann; K Elsner; J Kotzerke; G Glatting; M Rentschler; B Neumaier; H Träger; K Nüssle; S N Reske
Journal:  J Nucl Med       Date:  1999-10       Impact factor: 10.057

5.  Degenerative disc disease in the lumbar spine: another cause for focally reduced activity on marrow scintigraphy.

Authors:  M Cooper; K A Miles; E P Wraight; A K Dixon
Journal:  Skeletal Radiol       Date:  1992       Impact factor: 2.199

6.  Radioimmunoimaging for diagnosis of bone marrow involvement in breast cancer and malignant lymphoma.

Authors:  S N Reske; J H Karstens; W Gloeckner; A Steinsträsser; A Schwarz; J Ammon; U Buell
Journal:  Lancet       Date:  1989-02-11       Impact factor: 79.321

7.  The presence of tumor cells in bone marrow at the time of first recurrence of breast cancer.

Authors:  C Kamby; B Guldhammer; I Vejborg; N Rossing; H Dirksen; S Daugaard; H T Mouridsen
Journal:  Cancer       Date:  1987-09-15       Impact factor: 6.860

8.  A comparison of fluorine-18 fluoro-deoxyglucose PET and technetium-99m sestamibi in assessing patients with multiple myeloma.

Authors:  L Mileshkin; R Blum; J F Seymour; A Patrikeos; R J Hicks; H M Prince
Journal:  Eur J Haematol       Date:  2004-01       Impact factor: 2.997

Review 9.  Novel quantitative techniques for assessing regional and global function and structure based on modern imaging modalities: implications for normal variation, aging and diseased states.

Authors:  Sandip Basu; Habib Zaidi; Mohamed Houseni; Gonca Bural; Jay Udupa; Paul Acton; Drew A Torigian; Abass Alavi
Journal:  Semin Nucl Med       Date:  2007-05       Impact factor: 4.446

10.  Bone and marrow imaging: do we know what we see and do we see what we want to know?

Authors:  Giovanni Lucignani
Journal:  Eur J Nucl Med Mol Imaging       Date:  2007-07       Impact factor: 10.057
View more
  9 in total

1.  Critical considerations on the combined use of ¹⁸F-FDG and ¹⁸F-fluoride for PET assessment of metastatic bone disease.

Authors:  Gang Cheng; Thomas C Kwee; Sandip Basu; Abass Alavi
Journal:  Eur J Nucl Med Mol Imaging       Date:  2013-05-22       Impact factor: 9.236

2.  Simultaneous PET/MRI in the Evaluation of Breast and Prostate Cancer Using Combined Na[18F]F and [18F]FDG: a Focus on Skeletal Lesions.

Authors:  Poul F Høilund-Carlsen; Abass Alavi
Journal:  Mol Imaging Biol       Date:  2020-04       Impact factor: 3.488

3.  Comparisons between glucose analogue 2-deoxy-2-((18)F)fluoro-D-glucose and (18)F-sodium fluoride positron emission tomography/computed tomography in breast cancer patients with bone lesions.

Authors:  Selene Capitanio; Francesca Bongioanni; Arnoldo Piccardo; Claudio Campus; Roberta Gonella; Lucia Tixi; Mehrdad Naseri; Michele Pennone; Vania Altrinetti; Ambra Buschiazzo; Irene Bossert; Francesco Fiz; Andrea Bruno; Andrea DeCensi; Gianmario Sambuceti; Silvia Morbelli
Journal:  World J Radiol       Date:  2016-02-28

Review 4.  Evolving Role of Molecular Imaging with (18)F-Sodium Fluoride PET as a Biomarker for Calcium Metabolism.

Authors:  William Raynor; Sina Houshmand; Saeid Gholami; Sahra Emamzadehfard; Chamith S Rajapakse; Björn Alexander Blomberg; Thomas J Werner; Poul F Høilund-Carlsen; Joshua F Baker; Abass Alavi
Journal:  Curr Osteoporos Rep       Date:  2016-08       Impact factor: 5.096

5.  Whole-body MRI for the detection of bone marrow involvement in lymphoma: prospective study in 116 patients and comparison with FDG-PET.

Authors:  Hugo J A Adams; Thomas C Kwee; Malou A Vermoolen; Bart de Keizer; John M H de Klerk; Judit A Adam; Rob Fijnheer; Marie José Kersten; Jaap Stoker; Rutger A J Nievelstein
Journal:  Eur Radiol       Date:  2013-04-17       Impact factor: 5.315

6.  Evaluation of radiographic and metabolic changes in bone metastases in response to systemic therapy with (18)FDG-PET/CT.

Authors:  Bengul Gunalp; Ali Ozan Oner; Semra Ince; Engin Alagoz; Aslı Ayan; Nuri Arslan
Journal:  Radiol Oncol       Date:  2015-03-25       Impact factor: 2.991

7.  Cancer metastasizes to the bone marrow and not to the bone: time for a paradigm shift!

Authors:  Poul Flemming Høilund-Carlsen; Søren Hess; Thomas J Werner; Abass Alavi
Journal:  Eur J Nucl Med Mol Imaging       Date:  2018-06       Impact factor: 9.236

8.  Increasing Role of FDG-PET/CT in Detecting Bone Marrow Metastasis of Solid Tumors in Adults: An Analysis of Ten Patients.

Authors:  Fatih Selcukbiricik; Ozcan Yildiz; Sabire Yilmaz; Deniz Tural; Hande Turna; Nil Molinas Mandel; Nukhet Tuzuner; Suheyla Serdengecti; Metin Halac
Journal:  World J Oncol       Date:  2013-01-04

9.  The value of prebiopsy FDG-PET/CT in discriminating malignant from benign vertebral bone lesions in a predominantly oncologic population.

Authors:  Naila Loudini; Andor W J M Glaudemans; Paul C Jutte; Derya Yakar; Thomas C Kwee
Journal:  Skeletal Radiol       Date:  2020-04-06       Impact factor: 2.199
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.